Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Jan 24, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $47.29B | $357.98 | -3.25% | $151.92M | 1,154.77x | 19.74 | United States | 43 |
| PTC | PTC INC | NASDAQ | Software - Application | A | $19.37B | $162.14 | -1.56% | $1.13B | 26.49x | 0.73 | United States | 48 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $13.58B | $136.18 | -0.87% | $679.20M | 31.60x | 0.42 | United States | 62 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.25B | $168.71 | -1.34% | $182.64M | -28.17x | 1.87 | Ireland | 16 |
| INDV | INDIVIOR PLC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $4.12B | $32.97 | -1.70% | $316.00M | 25.17x | -7.84 | United Kingdom | 36 |
| CALX | CALIX INC | NYSE | Software - Application | A | $3.59B | $54.19 | -2.89% | $10.21M | -541.90x | 0.19 | United States | 33 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.77B | $48.25 | -1.73% | $64.66M | -146.21x | 0.35 | United States | 33 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.05B | $158.50 | -0.95% | $301.16M | 9.18x | 1.82 | United States | 50 |
| EXTR | EXTREME NETWORKS INC | NASDAQ | Communication Equipment | A | $1.97B | $14.75 | -2.90% | $65.83M | 210.71x | 15.82 | United States | 34 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.57B | $49.57 | -0.98% | $194.43M | 12.36x | 1.45 | United States | 46 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $1.20B | $4.15 | 0.24% | $137.29M | 51.88x | 0.68 | United States | 41 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $929.28M | $12.78 | -2.81% | $98.00M | 13.18x | 0.23 | United States | 47 |
| SMP | STANDARD MOTOR PRODUCTS INC | NYSE | Auto Parts | A | $864.57M | $39.30 | -1.06% | $129.61M | 27.68x | 1.97 | United States | 44 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $809.21M | $28.85 | -1.70% | $174.52M | 6.59x | 5.24 | United States | 39 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $709.76M | $19.02 | -2.16% | $145.14M | N/A | 6.80 | Mexico | 24 |
| EMBC | EMBECTA CORP | NASDAQ | Medical Instruments & Supplies | A | $640.13M | $10.94 | -9.44% | $294.70M | 6.67x | -2.68 | United States | 41 |
| VREX | VAREX IMAGING CORP | NASDAQ | Medical Devices | A | $577.55M | $13.85 | -3.55% | -$1.00M | -8.15x | 1.31 | United States | 20 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $497.50M | $3.92 | -2.00% | $18.04M | -32.67x | 0.49 | United States | 24 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $429.24M | $14.05 | -6.46% | $86.84M | 37.97x | 2.69 | United States | 39 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $238.37M | $28.58 | 4.38% | $12.05M | 29.46x | 0.20 | United States | 51 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $232.92M | $1.68 | -1.75% | $51.06M | -42.00x | 4.04 | United States | 12 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $222.20M | $11.92 | -0.33% | $11.65M | N/A | 0.39 | United States | 27 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $172.45M | $8.48 | -1.97% | $24.16M | 32.62x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.